<DOC>
	<DOCNO>NCT01645761</DOCNO>
	<brief_summary>Endonase , kind protease , know cause extensive degradation mucin reduction mucus viscosity . As part search effective form therapy H. pylorus colonize surface surface mucosal cell also surface mucous gel layer cover mucosal surface stomach . The investigator decide investigate whether endonase might additive effect pronase efficacy eradication therapy Helicobacter pylorus .</brief_summary>
	<brief_title>Additive Effect Endonase Eradication Rate First Line Therapy Helicobacter Pylori</brief_title>
	<detailed_description />
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>Male Female 18 year age without history H. pylorus eradication AND 1 . Patients H. pylori associate peptic ulcer scar stage , OR 2 . Nonulcer dyspepsia patient H. pylori infection 1 . Under 18 year , OR 2 . Patients history previous treatment H. pylorus infection , OR 3 . Pregnant Breast feeding woman , OR 4 . Patients severe renal , liver , heart disease , OR 5 . Patients gastric malignancy , OR 6 . Patients history drug allergy hypersensitivity , OR 7 . Patients receive treatment antibiotic proton pump inhibitor , H2 Blocker , Bismuth preparation , Anticoagulant , Ketoconazole , Glucocorticoid 2 week precede endoscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Helicobacter pylorus eradication</keyword>
	<keyword>Peptic ulcer</keyword>
</DOC>